Immunohistochemical staining showed decreased expression of TCF3 and increased expression of Nanog in PLC/PRF/5 miR-449a-overexpressing xenografted tumors compared with control xenografted tumors, suggesting that miR-449a can also regulate HCC stemness in vivo (Figure 6C, 6D). Here, NANOG is linked to hepatocellular carcinoma.